HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Research Dictionary Pharma Mobile

Sign Up FREE or Login

AT 130

Subscribe to New Research on AT 130

an anti-HIV agent; structure in first source

Also Known As:

AT-130; AT130 cpd

Networked: 122 relevant articles (4 outcomes, 14 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 58
- Amides: 231
  - Benzamides: 80
    - AT 130: 122
- Carboxylic Acids: 83
  - Carbocyclic Acids
    - Benzoic Acids: 18
      - Benzamides: 80
        AT 130: 122

Experts

1.	Arroyo, Juan A: 2 articles (03/2012 - 10/2007)
2.	Galan, Henry L: 2 articles (03/2012 - 10/2007)
3.	Li, Chun-Sheng: 2 articles (01/2012 - 09/2011)
4.	Rocha, Luisa: 2 articles (01/2012 - 09/2011)
5.	Lu, Yi: 2 articles (01/2012 - 09/2011)
6.	Côté, Mélanie: 2 articles (03/2010 - 07/2009)
7.	Lemieux, Isabelle: 2 articles (03/2010 - 07/2009)
8.	Cartier, Amélie: 2 articles (03/2010 - 07/2009)
9.	Tremblay, Angelo: 2 articles (03/2010 - 07/2009)
10.	Després, Jean-Pierre: 2 articles (03/2010 - 07/2009)

Related Diseases

1.	Hypokinesia (Bradykinesia) 08/01/2004 - "Stimulation at 130 Hz slightly worsened bradykinesia overall, whereas 40 Hz had little effect. " 07/15/2008 - "Stimulation at 130 Hz caused a rapid amelioration of chorea producing the worsening of bradykinesia, whereas 40 Hz stimulation (maintaining constant the total electrical energy delivered) improved chorea while preserving the ability to walk. " 08/01/2001 - "Long-term stimulation at 130 Hz, 0.09 to 0.450 milliseconds, and 1.5 to 3.0 V produced significant improvement in tremor and rigidity and mild improvement in bradykinesia. "
2.	Colorectal Neoplasms (Colorectal Cancer) 12/01/2002 - "In a large multicenter phase II trial for patients with metastatic colorectal cancer (N = 96), first-line treatment with oral capecitabine at 1,000 mg/m2 twice daily for 14 days and oxaliplatin at 130 mg/m2 by 2-hour infusion on day 1 every 21 days produced objective response in 55% of patients and stable disease (greater than 3 months) in a further 32%. " 03/01/2002 - "A group of 29 patients with advanced colorectal cancer refractory to prior weekly 8-h 5-FU infusion plus bolus folinic acid (FA), received the same combination plus OXA at 130 mg/m(2) every 3 weeks, OXA plus 5-FU plus FA on day 1, and 5-FU plus FA on days 8 and 15. "
3.	Tremor (Tremors) 08/01/2001 - "Long-term stimulation at 130 Hz, 0.09 to 0.450 milliseconds, and 1.5 to 3.0 V produced significant improvement in tremor and rigidity and mild improvement in bradykinesia. "
4.	Parkinson Disease (Parkinson's Disease) 07/08/2008 - "The number of freezing episodes was significantly lower at the 60-Hz "high voltage/equivalent energy" and higher at the 130-Hz/high voltage than for "off stimulation." The slight improvement in the Unified Parkinson's Disease Rating Scale motor score observed (at 130 Hz) did not achieve statistical significance. " 07/08/2008 - "Our results prompt consideration of a new strategy for two-stage subthalamic nucleus deep brain stimulation (STN-DBS) frequency optimization, with stimulation at 130 Hz and the usual voltage during the initial years of STN-DBS and then at 60 Hz at a high voltage in Parkinson disease patients who develop severe gait disorders."
5.	Chorea (Rheumatic Chorea) 07/15/2008 - "Stimulation at 130 Hz caused a rapid amelioration of chorea producing the worsening of bradykinesia, whereas 40 Hz stimulation (maintaining constant the total electrical energy delivered) improved chorea while preserving the ability to walk. "

Related Drugs and Biologics

1.	oxaliplatin (Eloxatin)
2.	capecitabine (Xeloda)
3.	gamma-Aminobutyric Acid (GABA)
4.	Leukocyte L1 Antigen Complex (Calgranulin)
5.	P-Glycoprotein
6.	Glutamic Acid (Glutamate)
7.	Dinoprostone (PGE2)
8.	Verapamil (Calan)
9.	Hydrocortisone (Cortisol)
10.	Viral DNA

Related Therapies and Procedures

1.	Deep Brain Stimulation
2.	Transplants (Transplant)
3.	Cardiopulmonary Bypass (Heart-Lung Bypass)
4.	Coronary Artery Bypass (Coronary Artery Bypass Surgery)
5.	Intravenous Infusions